CANRENONE AND ANDROGEN RECEPTOR-ACTIVE MATERIALS IN PLASMA OF CIRRHOTIC-PATIENTS DURING LONG-TERM K-CANRENOATE OR SPIRONOLACTONE THERAPY

被引：12

作者：

ANDRIULLI, A

ARRIGONI, A

GINDRO, T

KARBOWIAK, I

BUZZETTI, G

ARMANINI, D

机构：

[1] OSPED SANTO SPIRITO,DIV MED,BRA,ITALY

[2] OSPED NIGUARDA CA GRANDA,SERV DIETOL,MILAN,ITALY

[3] UNIV PADUA,IST SEMEIOT MED,I-35100 PADUA,ITALY

来源：

DIGESTION | 1989年 / 44卷 / 03期

关键词：

D O I：

10.1159/000199905

中图分类号：

R57 [消化系及腹部疾病];

学科分类号：

摘要：

引用

页码：155 / 162

页数：8

共 22 条

[1] INVIVO METABOLITES OF SPIRONOLACTONE AND POTASSIUM-CANRENOATE - DETERMINATION OF POTENTIAL ANTI-ANDROGENIC ACTIVITY BY A MOUSE KIDNEY CYTOSOL RECEPTOR ASSAY [J].

ARMANINI, D ;

KARBOWIAK, I ;

GOI, A ;

MANTERO, F ;

FUNDER, JW .

CLINICAL ENDOCRINOLOGY, 1985, 23 (04) :341-347

[2]

ARMANINI D, 1987, CORTICOSTEROID PEPTI, V39, P285

[3]

ARRIGONI A, 1988, BRIT J CLIN PRACT, V42, P116

[4]

BELLATI G, 1986, LANCET, V1, P626

[5] DOUBLE-BLIND, CONTROLLED, CLINICAL TRIAL OF SPIRONOLACTONE FOR BENIGN PROSTATIC HYPERTROPHY [J].

CASTRO, JE ;

GRIFFITHS, HJ ;

EDWARDS, DE .

BRITISH JOURNAL OF SURGERY, 1971, 58 (07) :485-+

[6]

Child C G, 1964, Major Probl Clin Surg, V1, P1

[7] ANTIANDROGENIC EFFECT OF SPIROLACTONES - MECHANISM OF ACTION [J].

CORVOL, P ;

MICHAUD, A ;

MENARD, J ;

FREIFELD, M ;

MAHOUDEAU, J .

ENDOCRINOLOGY, 1975, 97 (01) :52-58

[8]

DAHLOF CG, 1979, DRUG METAB DISPOS, V7, P103

[9]

DUPONT A, 1985, LANCET, V2, P731

[10] MOLECULAR MODIFICATIONS OF ANTI-ALDOSTERONE COMPOUNDS - EFFECTS ON AFFINITY OF SPIRONOLACTONES FOR RENAL ALDOSTERONE RECEPTORS [J].

FUNDER, JW ;

FELDMAN, D ;

HIGHLAND, E ;

EDELMAN, IS .

BIOCHEMICAL PHARMACOLOGY, 1974, 23 (10) :1493-1501

← 1 2 3 →